BreadcrumbHome / Investors / Press Releases Press Releases Jump Links - All Pages OverviewPress ReleasesEvents and PresentationsSEC FilingsCorporate GovernanceStock Information Keyword Search Year None202520242023202220212020201920182017201620152014 January 17, 2025 Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 14, 2025 Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR January 8, 2025 Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation Additional Resources Investor FAQsInformation Request
Keyword Search Year None202520242023202220212020201920182017201620152014 January 17, 2025 Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 14, 2025 Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR January 8, 2025 Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
January 14, 2025 Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
January 8, 2025 Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
